The rise and fall of NMDA antagonists for ischemic stroke.
It has long been accepted that high concentrations of glutamate can destroy neurons, and this is the basis of the theory of excitotoxicity during brain injury such as stroke. Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists such as Selfotel, Aptiganel, Gavestinel and others failed to show...
Автори: | Hoyte, L, Barber, P, Buchan, A, Hill, MD |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2004
|
Схожі ресурси
Схожі ресурси
-
NMDA antagonists: their role in neuroprotection.
за авторством: Small, D, та інші
Опубліковано: (1997) -
NMDA antagonists: their role in neuroprotection.
за авторством: Small, D, та інші
Опубліковано: (1997) -
Do NMDA antagonists prevent neuronal injury? No.
за авторством: Buchan, A
Опубліковано: (1992) -
AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
за авторством: Buchan, A, та інші
Опубліковано: (1993) -
The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
за авторством: Buchan, A, та інші
Опубліковано: (1992)